neuroClues® is an innovative eye-tracking solution developed by P3Lab, designed to assist healthcare practitioners in the early detection and monitoring of neurological disorders. By analyzing eye movements, neuroClues® provides non-invasive, rapid, and robust biomarkers that enhance clinical examinations. This technology aims to identify conditions such as Parkinson's disease, Alzheimer's disease, and Multiple Sclerosis years before visible symptoms appear, thereby facilitating timely interventions and improved patient outcomes.